The DOI matches its Crossref record.
Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis
Abstract
BACKGROUND: Topical steroids are used as the first-line therapy for atopic dermatitis. OBJECTIVES: To determine the clinical doses of topical steroids for the daily treatment of atopic dermatitis in clinics and to elucidate their adverse effects. PATIENTS AND METHODS: A multicentre retrospective analysis of a series of 1271 patients (210 infants, 546 children, and 515 adolescents and adults) with atopic dermatitis. RESULTS: Less than 89.5 g, 135 g and 304 g of topical steroid were applied in 90% of the patients in the infant, childhood, and adolescent and adult AD groups, respectively, on the entire body during the 6-month treatment period. The majority of patients were controlled well; however, 7% of infant, 10% of childhood and 19% of adolescent and adult patients remained in a very severe or severe state or experienced exacerbation even though they applied larger amounts of topical steroids. With regard to adverse effects, the incidence of telangiectasia on cheeks tended to increase in patients who had a longer duration of disease and who applied more than 20 g to the face during the 6-month treatment period. The steroid-induced atrophy of the antecubital and popliteal fossae was more frequently observed in males than in females. CONCLUSIONS: Topical steroids are useful for treating atopic dermatitis, but a substantial percentage of patients cannot be satisfactorily treated with topical steroids. For such patients, adjustments of dose and rank of topical steroids and other therapeutic adjuncts are necessary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Cork, M. J., Robinson, D. A., Vasilopoulos, Y., Ferguson, A., Moustafa, M., MacGowan, A., Duff, G. W., Ward, S. J., & Tazi-Ahnini, R. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.04.042 · Cited by 525
Developmental Pharmacokinetics in Pediatric Populations
Lu, H., & Rosenbaum, S. (2014) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-19.4.262 · Cited by 358
Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency
Aubert‐Wastiaux, H., Moret, L., Le Rhun, A., Fontenoy, A. M., Nguyen, J. M., Leux, C., Misery, L., Young, P., Chastaing, M., Danou, N., et al. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10449.x · Cited by 269
Chemokines: Roles in leukocyte development, trafficking, and effector function
Ono, S. J., Nakamura, T., Miyazaki, D., Ohbayashi, M., Dawson, M., & Toda, M. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.1594 · Cited by 257
Siegfried, E. C., Jaworski, J. C., Kaiser, J. D., & Hebert, A. A. (2016) · BMC Pediatrics · doi:10.1186/s12887-016-0607-9 · Cited by 194
Metadata
- Authors
- Furue, M., Terao, H., Rikihisa, W., Urabe, K., Kinukawa, N., Nose, Y., & Koga, T.
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-01
- Volume
- 148
- Issue
- 1
- Pages
- 128-133
- ISSN
- 0007-0963 (ISSN-L)
- 1365-2133
- OpenAlex
- W2129117240
- Cited by
- 183
- References
- 0
- FWCI
- 7.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis. https://app.cochat.ai/papers/10.1046/j.1365-2133.2003.04934.x
- The paper
- Furue, M., Terao, H., Rikihisa, W., Urabe, K., Kinukawa, N., Nose, Y., & Koga, T. (2003). Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis. British Journal of Dermatology. https://doi.org/10.1046/j.1365-2133.2003.04934.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.